Clinical trial
A Perspective Trial of Sodium Glycididazole Combined With Concurrent Chemoradiotherapy for Locally Recurrent Squamous Cell Esophageal Carcinoma
NCT02721576 is registered in ClinicalTrials.gov with Shandong Cancer Hospital and Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Perspective Trial of Sodium Glycididazole Combined With Concurrent Chemoradiotherapy for Locally Recurrent Squamous Cell Esophageal Carcinoma
- Lead sponsor
- Shandong Cancer Hospital and Institute
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- July 5, 2016
- Completion date
- July 30, 2018
- Enrollment
- 8 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.